Finance, Forex and Investments

Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex Late Stage Innovative PR Newswire via Yahoo Finance jpg

Summary: strengthens Teva s oncology offerings with novel therapeutic designed to target resistance to cancer treatments JERUSALEM Israel BOTHELL WA and VANCOUVER Canada Dec Tags travel

Image Dimensions: 468 x 351